MARGINAL ZONE LYMPHOMA
Clinical trials for MARGINAL ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to fight cancer without harsh chemo
Disease control TerminatedThis study tested a combination of two immunotherapy drugs, pembrolizumab and rituximab, for adults with marginal zone lymphoma who needed treatment. The goal was to see if this chemotherapy-free approach could control the cancer as well as standard treatments that include chemot…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: University of Ulm • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Early-Stage trial tests immune therapy for untreated lymphoma
Disease control TerminatedThis study tested whether pembrolizumab, an immunotherapy drug, could help control certain slow-growing B-cell lymphomas in people who hadn't yet received any treatment. The goal was to see if boosting the body's immune system could attack the cancer cells. The trial was stopped …
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New drug combo tested to control blood cancers in First-Time patients
Disease control TerminatedThis study tested a two-drug combination as the first treatment for people newly diagnosed with certain slow-growing blood cancers called follicular lymphoma or marginal zone lymphoma. The goal was to see if adding the experimental drug umbralisib to the approved drug rituximab c…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New scan aims to spot hidden lymphoma tumors more accurately
Diagnosis TerminatedThis trial tested a new type of PET scan imaging agent called [68Ga]Ga-PTF to see if it could better detect and map out marginal zone lymphoma tumors compared to the standard FDG PET scan. The study involved patients with confirmed lymphoma who had not yet started treatment. The …
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE3 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC